Assembly Biosciences
ASMB
32 hedge funds and large institutions have $12M invested in Assembly Biosciences in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 7 closing their positions.
19% more capital invested
Capital invested by funds: $10.1M → $12M (+$1.91M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.26% less ownership
Funds ownership: 1.93% → 1.67% (-0.26%)
14% less funds holding
Funds holding: 37 → 32 (-5)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.3K |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$10.3K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$9.95K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$2.46K |
| 5 |
Morgan Stanley
New York
|
+$381 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
RhumbLine Advisers
Boston,
Massachusetts
| $2.76K | +$2.46K | +200 | New |
|
|
BAAM
27
Baker Avenue Asset Management
San Francisco,
California
| $1.15K | – | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $575 | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| $431 | +$37 | +3 | +11% |
|
30
JP Morgan Chase
New York
| $109 | – | – | – |
|
31
BNP Paribas Financial Markets
Paris,
France
| $37 | – | – | – |
|
|
PIM
32
Platinum Investment Management
Sydney Australia 2000,
Australia
| – | -$749K | -74,228 | Closed |
|
33
Dimensional Fund Advisors
Austin,
Texas
| – | -$239K | -23,682 | Closed |
|
34
Two Sigma Investments
New York
| – | -$32.2K | -3,192 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$26K | -2,597 | Closed |
|
36
Jane Street
New York
| – | -$20.4K | -2,025 | Closed |
|
|
VF
37
Virtu Financial
New York
| – | -$10K | -994 | Closed |
|
38
UBS Group
Zurich,
Switzerland
| – | -$8.9K | -883 | Closed |
|
|
ASN
39
Advisory Services Network
Atlanta,
Georgia
| – | -$1 | – | – |
|
40
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$344 | +28 | New |
|
ASMB Hedge Fund Activity: Q2 2023 in Review
32 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2023, worth a combined $12M — up 19% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ASMB and 3 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $56.3K. The largest seller was Platinum Investment Management, exiting entirely with an estimated $749K sold.
- 32 institutional investors held Assembly Biosciences (ASMB) as of Q2 2023, down from 37 in Q1 2023.
- Funds reported $12M of Assembly Biosciences stock for Q2 2023, up 19% quarter-over-quarter.
- 3 funds opened new Assembly Biosciences positions in Q2 2023 and 7 closed out, a net change of -4 holders.
- The largest Assembly Biosciences buyer in Q2 2023 was Geode Capital Management, an estimated $56.3K added.
- The largest Assembly Biosciences seller in Q2 2023 was Platinum Investment Management, an estimated $749K sold.
Based on aggregated 13F filings for Q2 2023.